So we dont know the history going back further, but I immediately I put everybody who would let me on a small dose of GLP 1 agonist when I started doing the research and all for entirely different reasons, looking for entirely different outcomes, just to see how it would, um, pan out because I had data showing efficacy for all of these things
Injection Frequency: Administer once weekly
For individuals with metabolic dysfunction-associated steatotic liver disease, formerly called non-alcoholic fatty liver disease, that difference could mean the gap between disease progression and reversal
Even though there is an early worsening of retinopathy, it is not a permanent change and is expected to improve over time
By helping to regulate blood sugar levels and control appetite, it can improve health outcomes and quality of life